Skip to main content
Log in

Iontophoretically enhanced transdermal delivery of an ACE inhibitor in induced hypertensive rabbits: Preliminary report

  • Experimental Pharmacology
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Both conventional direct current (DC) and pulsedmode DC constant-current iontophoresis were used to investigate enhanced transdermal delivery of the angiotensin-converting enzyme (ACE) inhibitor captopril to rabbits with acutely induced hypertension. Passive transdermal captopril administration and pulsed DC constant-current iontophoresis of the vehicle were studied as control experimentation. Mean arterial pressure (MAP) was not significantly (p>0.05) altered following passive transdermal delivery of captopril (n=4) or after iontophoretic delivery of the vehicle alone (n=4). Pressure reduction was evident within 10 minutes of iontophoretic enhancement of transdermal captopril delivery. DC mode constant-current (n=4) iontophoretic transdermal captopril administration caused MAP to fall by 21% from a mean hypertensive level of 66±5 mmHg to a mean post-treatment level of 52±6 mmHg (p<0.05) within 60 minutes. Pulsed DC mode constant-current (n=4) iontophoresis of captopril caused mean MAP to fall on average by 27% from 62±6 to 45±5 mmHg (p<0.05), also within 60 minutes. This paper provides the first report on the enhanced efficiency during iontophoretic delivery of an ACE inhibitor. We have concluded that both modes of constant-current iontophoresis of captopril offer a safe and effective means of pressure reduction in rabbits with induced hypertension and that there is no significant difference in efficacy between the two forms of enhanced delivery. These results have potential applications for enhanced transdermal delivery of ACE inhibitors in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Guy RH, Hadgraft J. Selection of drug candidates for transdermal drug delivery. In: Hadgraft J, Guy RH, eds. Transdermal drug delivery: Developmental issues and research initiatives. New York: Marcel Dekker, 1989:59–81.

    Google Scholar 

  2. Spieker C, Vetter H, Liedtke R, et al. Transdermal betablocker therapy in essential hypertension. Am J Hypertens 1988;1 (Suppl 3):199S-200S.

    Google Scholar 

  3. Singh J, Roberts MS. Transdermal delivery of drugs by iontophoresis: A review. Drug Des Delivery 1989;4:1–12.

    Google Scholar 

  4. Lawler JC, Davis MJ, Griffith EC. Electrical characteristics of the skin: The impedance of the surface sheath and deep tissues. J Invest Dermatol 1960;34:301–308.

    Google Scholar 

  5. Davis DR, Kennard DW. Influence of electric current on the skin. Nature 1962;193:1186–1187.

    Google Scholar 

  6. Okabe K, Yamaguchi H, Kawai Y. New iontophoretic transdermal administration of the beta-blocker metoprolol. J Controlled Release 1986;4:79–85.

    Google Scholar 

  7. Zakzewski CA, Li J K-J. Pulsed mode constant current iontophoretic transdermal metoprolol tartrate delivery in established acute hypertensive rabbits. J Controlled Release 1991;17:157–162.

    Google Scholar 

  8. Burnette RR. Iontophoresis. In: Hadgraft J, Guy RH, eds. Transdermal drug delivery: Developmental issues and research initiatives. New York: Marcel Dekker, 1989:247–291.

    Google Scholar 

  9. Flynn GL. Mechanism of percutaneous absorption from physicochemical evidence. In: Bronaugh RL, Maibach HI, eds. Percutaneous absorption: Mechanisms—methodology—drug delivery, 2nd ed. New York: Marcel Dekker, 1989:27–51.

    Google Scholar 

  10. Hansch C, Sammes PG, Taylor JB, eds. Comprehensive medicinal chemistry: The rational design, mechanistic studies, & therapeutic application of chemical compounds, Vol. 6. New York: Pergamon Press, 1990.

    Google Scholar 

  11. Teorell T. Transport processes and electrical phenomena in ionic membranes. Prog Biophys Mol Biol 1953;3:305–369.

    Google Scholar 

  12. Edelberg R. Electrical properties of skin. In: Elden HR, ed. Biophysical properties of the skin. New York: John Wiley & Sons, 1971:513–550.

    Google Scholar 

  13. Yamamoto T, Yamamoto Y. Electrical properties of the epidermal stratum corneum. Med Biol Eng 1976;14:151–158.

    Google Scholar 

  14. Rosell J, Colominas J, Riu P, et al. Skin impedance from 1 Hz to 1 MHz. IEEE Trans Biomed Eng 1988;35(8):649–651.

    Google Scholar 

  15. Foster SB, Kousch D. Adherence to therapy in hypertensive patients. Nurs Clin North Am 1981;16(2):331–341.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zakzewski, C.A., Amory, D.W., Jasaitis, D.K. et al. Iontophoretically enhanced transdermal delivery of an ACE inhibitor in induced hypertensive rabbits: Preliminary report. Cardiovasc Drug Ther 6, 589–595 (1992). https://doi.org/10.1007/BF00052560

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00052560

Key words

Navigation